Clinical value and application of SPINK1 as a tumor biomarker
10.3760/cma.j.cn371439-20200216-00047
- VernacularTitle:SPINK1作为肿瘤标志物的临床价值与应用
- Author:
Na ZHAO
1
;
Yang ZHENG
;
Lili CHEN
;
Donghui JING
;
Huaqing WANG
Author Information
1. 灏灵赛奥（天津）生物科技有限公司研发部 300457
- From:
Journal of International Oncology
2020;47(7):414-418
- CountryChina
- Language:Chinese
-
Abstract:
The serine protease inhibitor Kazal type 1 (SPINK1) is a member of the protease inhibitor family. As SPINK1 plays an essential role in the occurrence, development and prognosis of tumors, such as ovarian cancer, pancreatic cancer, hepatocellular carcinoma, colorectal cancer and prostate cancer, the clinical application of SPINK1 as a tumor marker has been widely concerned by researchers.
